David Stoll, M.D.
NPI 1457330169 · Specialist · Beverly Hills, CA
Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
David Stoll, M.D. is a Specialist provider in Beverly Hills, CA (NPI 1457330169).
Provider details
- NPI number
- 1457330169
- Entity type
- Individual
- Primary specialty
- SpecialistOther Service Providers
- Credential
- M.D.
- Sex
- Male
- Sole proprietor
- Yes
- License
- G045943 (CA)
Specialties & taxonomies
Other Service Providers
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
20 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
1,260 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 621 | $92 |
| Destruction of Precancer Skin Growth, 15 Or More Growths17004 | 333 | $175 |
| New Patient Office Or Other Outpatient Visit With Low Level of Medical Decision Making, If Using Time, 30 Minutes Or More99203 | 109 | $113 |
| Destruction of Precancer Skin Growth, 1 Growth17000 | 60 | $71 |
| Complicated Or Multiple Drainage of Skin Abscess10061 | 56 | $220 |
| Destruction of Skin Growth, 1-14 Growths17110 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 16 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Triamcinolone Acetonide | 78 | 53 |
| Fluocinonide | 57 | 41 |
| Mupirocin | 41 | 27 |
| Ciclopirox Olaminebrand: Ciclopirox | 37 | 24 |
| Betamethasone Dipropionate | 27 | 18 |
| Alclometasone Dipropionate | 26 | 21 |
| Minoxidil | 25 | — |
| Clobetasol Propionate | 23 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$776 across 33 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-01-11
- Last updated
- 2012-10-04
Frequently asked questions
- What is David Stoll's NPI number?
- David Stoll's National Provider Identifier (NPI) is 1457330169, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is David Stoll's specialty?
- David Stoll is listed in the NPPES registry with a primary specialty of Specialist (Other Service Providers).
- Where is David Stoll located?
- David Stoll's practice location on file with NPPES is 9735 Wilshire Blvd, Beverly Hills, CA 90212-2107.
- What is David Stoll's phone number?
- The practice phone number listed in the NPPES registry for David Stoll is (310) 273-6558.
- Does David Stoll accept Medicare?
- David Stoll is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is David Stoll's NPI active?
- Yes — David Stoll's NPI (1457330169) is active in the NPPES registry as of the last update on 2012-10-04.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.